Early-stage studies of medications to treat high-risk alcohol use may be missing opportunities to identify potential therapeutic effects in certain populations, including women and people at risk for relapse, according to a systematic review published […]
A new analysis presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) examined daily oral orforglipron treatment for the treatment of obesity, with or without diabetes, in users aged 65 years […]
Many people with major depressive disorder get no relief from current treatments. Newer combinations of existing medications might help, researchers report in JAMA Psychiatry.This article was originally published on MedicalXpress.com
A research team from Department of Pharmacology and Pharmacy at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the InnoHK Advanced Biomedical Instrumentation Centre (ABIC), has developed the world’s […]
A new federal initiative aims to curb “overprescribing” of psychiatric medications while emphasizing holistic care.This article was originally published on MedicalXpress.com
For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the New England Journal of Medicine.This article was originally published on MedicalXpress.com
Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical changes in how the liver and kidneys process therapeutic drugs. The experimental technology, under development at […]
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer […]
For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new Northwestern University study in mice has found […]
The U.S. Food and Drug Administration has approved the expanded use of Axsome Therapeutics’ Auvelity (dextromethorphan hydrobromide and bupropion hydrochloride) extended-release tablets to treat adults with agitation associated with dementia due to Alzheimer’s disease.This article […]
© 2025 SimplyWell.ca